U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07639996) titled 'Natural Course and Molecular Basis of Alpha 1- Antitrypsin Deficiency-associated Liver Disease.' on June 01.
Brief Summary: * To define the course of AATD-associated liver disease.
* To use the obtained samples for biomedical research which includes:
1. Search for serum-based disease biomarkers and the associated molecular pathways.
2. Multi-omic spatial analysis of human AATD-LD.
Study Start Date: Oct. 01, 2026
Study Type: OBSERVATIONAL
Condition:
Alpha 1-antitrypsin Deficiency (AATD)
Intervention:
DIAGNOSTIC_TEST: Multi-omic spatial analysis
conduction of spatial multi-omic analyses comparing pediatric and adult liver ti...